ASH 2017 Roundtable: Multiple Myeloma Research News and Updates From an Expert Panel

ASH 2017 Roundtable: Multiple Myeloma Research News and Updates From an Expert Panel

/in , , /by

ASH 2017 Roundtable: Multiple Myeloma Research News and Updates From an Expert Panel from Patient Empowerment Network on Vimeo.

At the 2017 America Society of Hematology (ASH) annual meeting, a roundtable of myeloma experts share breaking news and the expansion of the treatment armamentarium in and implications for different disease status. The panel includes:

  • Dr. Carol Ann Huff of Johns Hopkins University School of Medicine
  • Dr. Sagar Lonial of Emory University School of Medicine
  • Dr. Suzanne Lentzsch fof New York Presbyterian Hospital/Columbia University Medical Center
  • Jenny Ahlstrom, President and Founder of Myeloma Crowd
You might also like
Will Telemedicine Be a Long-Term Survival Tool for Myeloma Patients? Will Telemedicine Be a Long-Term Survival Tool for Myeloma Patients?
Is Multiple Myeloma Hereditary Is Multiple Myeloma Hereditary? What you need to know
Diagnosed with Myeloma? Why to See a Specialist and What to Expect Diagnosed with Myeloma? Why to See a Specialist and What to Expect
ASH 2019: Timely Myeloma Care Makes a World of Difference; Experts Prioritize Addressing Race-Associated Risks ASH 2019: Timely Myeloma Care Makes a World of Difference; Experts Prioritize Addressing Race-Associated Risks
Myths vs. Facts: Myeloma Health Disparities Care Infographic Myths vs. Facts: Myeloma Health Disparities Care Infographic
How Is Minimal Residual Disease (MRD) Testing Used in Myeloma Care_ How Is Minimal Residual Disease (MRD) Testing Used in Myeloma Care?